Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

Session Overview
PPS1: Preclinical and Pharmaceutical Statistics I (Clinical Drug Development)
Tuesday, 19/Mar/2019:
9:00am - 10:40am

Session Chair: Antonia Zapf
Session Chair: Ann-Kathrin Ozga
Location: A 021
Verfügbar: Mo-Fr, je 7-23 Uhr Plätze: 126 Technikausstattung: BE, DIA, DVD, MF, MP, TE Bestuhlung: fest Grüne Tafel: nein

Show help for 'Increase or decrease the abstract text size'
9:00am - 9:40am

Statistical issues in drug development and the role of statisticians in regulatory agencies

Benjamin Hofner

Paul-Ehrlich-Institut (PEI), Germany

9:40am - 10:00am

Adjusting for selection bias in assessing treatment effect estimates from multiple subgroups

Ekkehard Glimm

Novartis Pharma, Switzerland

10:00am - 10:20am

An efficient phase II/III development program utilizing information on short-term response and long-term survival

Heiko Götte1, Junyuan Xiong2, Marietta Kirchner3, Meinhard Kieser3

1Merck KGaA, Darmstadt, Germany; 2EMD Serono, Billerica, MA, USA; 3Institute of Medical Biometry and Informatics, University of Heidelberg, Germany

10:20am - 10:40am

Quantification of prior impact in terms of prior effective historical and current sample size

Manuel Wiesenfarth, Silvia Calderazzo

German Cancer Research Center, Germany

Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: DAGStat 2019
Conference Software - ConfTool Pro 2.6.129+TC
© 2001 - 2019 by Dr. H. Weinreich, Hamburg, Germany